This is an old revision of the document!
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria.
Affiliations
Funding
CARB-X is funded by the Bill & Melinda Gates Foundation, Biomedical Advanced Research and Development Authority (BARDA), German Federal Ministry of Education and Research, United Kingdom Department of Health and Social Care (through the Global Antimicrobial Resistance Innovation Fund, Wellcome Trust